高级检索
陈玲萍, 吕文莉, 平其能. 盐酸安非他酮缓释微丸的制备及生物利用度研究[J]. 中国药科大学学报, 2009, 40(5): 421-425.
引用本文: 陈玲萍, 吕文莉, 平其能. 盐酸安非他酮缓释微丸的制备及生物利用度研究[J]. 中国药科大学学报, 2009, 40(5): 421-425.
CHEN Ling-ping, L Wen-li, PING Qi-neng. Preparation and bioavailability of bupropion hydrochloride sustained-release pellets[J]. Journal of China Pharmaceutical University, 2009, 40(5): 421-425.
Citation: CHEN Ling-ping, L Wen-li, PING Qi-neng. Preparation and bioavailability of bupropion hydrochloride sustained-release pellets[J]. Journal of China Pharmaceutical University, 2009, 40(5): 421-425.

盐酸安非他酮缓释微丸的制备及生物利用度研究

Preparation and bioavailability of bupropion hydrochloride sustained-release pellets

  • 摘要: 目的 : 研制盐酸安非他酮(bupropion hydrochloride,BH)24 h缓释微丸,并以市售片剂为对照,进行生物利用度研究。 方法 : 采用挤出滚圆法制备含药丸心,以乙基纤维素水分散体为包衣材料进行流化床包衣,将BH缓释微丸和市售片剂大鼠灌胃后测定生物利用度,用HPLC法测定血药浓度,采用Kinetica软件计算药动学参数。 结果 : BH缓释微丸在2,12和24 h的体外释放度分别约为10%,80%和95%。药动学 结果 表明BH缓释微丸的血药浓度经时曲线符合二室模型,市售片剂的血药浓度经时曲线符合一室模型,BH缓释微丸和市售片剂的AUC分别为(1 523.79±323.30) ng·h/mL和 (1 379.67±253.61) ng·h/mL;cmax分别为(163.80±32.93) ng/mL和(451.91±144.54) ng/mL;tmax分别为(4.67±0.52) h和(0.5±0) h。以市售片剂为对照,BH缓释微丸的相对生物利用度为(110.46±17.07)%。 结论 : 所研制的BH 24 h缓释微丸与市售BH普通片生物等效。

     

    Abstract: Aim :To prepare bupropion hydrochloride(BH) 24-hour sustained-release pellets and to determine its oral bioavailability in rats. Methods :BH 24-hour sustained-release pellets were prepared through the method of extrusion-spheronization and then were coated by ethyl cellulose-based aqueous disperse system using Mini-Glatt.And BH plasma concentrations in rats receiving administration of BH pellets or commercially available BH tablets were determined by HPLC.The pharmacokinetic parameters were estimated by Kinetica software. Results :The cumulative release percents of BH sustained-release pellets in 2,12 and 24 h were 10%,80% and 95%,respectively.The plasma concentration-time curves of BH sustained-release pellets and BH tablets in rats after oral administration were fitted to two-and one-compartment models,respectively.AUCs of BH sustained-release pellets and BH tablets were found to be (1 523.79±323.30) ng ·h/mL and(1 379.67±253.61) ng ·h/mL,respectively;cmaxs were(163.80±32.93) ng/mL and(451.91±144.54) ng/mL,respectively;and tmaxs were(4.67±0.52) h and(0.5±0) h respectively.The relative bioavailability of BH sustained-release pellets to commercial BH tablets was (110.46±17.07) %. Conclusion :The prepared BH 24-hour sustained-release pellets are bioequivalent to the commercial BH tablets.

     

/

返回文章
返回